Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-12-16

Clinical Trial Update: N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-acetylcysteine for alcohol use disorder in veterans with traumatic brain injury; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Traumatic Brain Injury (TBI), Hazardous and Harmful Alcohol Use | Phase 2 | Status: COMPLETED | Results posted: 2020-12-16